期刊文献+

铜绿假单胞菌耐药性在生物被膜形成过程中的变化 被引量:19

Change of intrinsic drug resistance in the formation of Pseudomonas aeruginosa biofilms
原文传递
导出
摘要 目的 研究铜绿假单胞菌遗传性耐药(gyrA基因突变和MexAB OprM主动外排)在生物被膜形成过程中对药物抗性的作用。方法 通过PCR技术鉴定gyrA基因突变株和MexAB OprM主动外排株,利用三亲杂交的方法将绿色荧光蛋白(GFP)基因转到铜绿假单胞菌药物敏感株中,测定gyrA基因突变株、MexAB OprM主动外排株以及带有绿色荧光蛋白的铜绿假单胞菌在特氟隆上产生生物被膜耐药的规律。结果 筛选出gyrA基因突变株和MexAB OprM主动外排株。通过三亲杂交成功构建了带有pGFPuv质粒的铜绿假单胞菌。将突变株和敏感株培养在最低杀菌浓度(MBC)的环丙沙星溶液中形成生物被膜使菌株的存活率均在50%以上。结论 比较遗传性耐药和生物被膜耐药的作用表明gyrA基因突变和主动外排在生物被膜耐药形成前期发挥主要作用,当生物被膜完全形成之后,铜绿假单胞菌的耐药性有可能是由生物被膜介导的。 Objective To screen gyrA mutant and multidrug resistance (MDR) efflux pump (MexAB-OprM) of Pseudomonas aeruginosa (Pa) and to identify the contribution of gyrA mutant and MDR efflux pump to bacterial drug resistance during the formation of Pa biofilms. Methods The strains of gyrA mutant and MDR efflux pump were clinical isolates and detected by PCR. Tri-relative hybridization experiments were performed to transfer report gene of GFP into sensitive Pa strains. The formation of bacterial biofilms was observed by scanning electron microscope followed by analysis of bacterial survival rate. Results The fluorescent strains with pGFPuv could form mature biofilms on Teflon surface. Over a period of 72 h, the survival rate of biofilm bacteria was more than 50% in its′ MBC of ciprofloxacin. Conclusion The express of gyrA mutation and MDR efflux played major roles in Pa resistance during the initial stage of biofilm development. But after 72 h of incubation, there was no significant difference between mutants and sensitive strains in terms of survival rate.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2005年第4期314-318,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30370079) 美国纽约中华基金会资助项目(CMB No.82 412)
  • 相关文献

参考文献14

  • 1Cachia PJ, Hodges RS. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa. Biopolymers, 2003, 71(2): 141-168.
  • 2Lisa S, Jane S. Infection control in cystic fibrosis. Clin Microbiol Rev, 2004, 17(1): 57-71.
  • 3Nathan EH, Hongwei Y. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect Immun, 2004, 72(1 ): 133-144.
  • 4Sahm DF, Washington Ⅱ JA. Antibacterial susceptibility tests: dilotion methods. Manual of Clinical Microbiology,the fifth edition. American society for microbiolody (ASM) press, Washington, 1991, 1105-1111.
  • 5李学如,贾文祥,杨春,刘莉,曾蔚,杨远,马巨辉,张再蓉,程曦.铜绿假单胞菌环丙沙星耐药株Ⅱ类拓扑异构酶基因突变的研究[J].中国抗生素杂志,2003,28(3):155-159. 被引量:14
  • 6Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol, 2000, 182(10): 2675-2679.
  • 7Xian-Zhi L, Keith P. Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol, 2001, 183(1): 12-27.
  • 8Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1 an opportunistic pathogen. Nature, 2000, 406(6799): 959-964.
  • 9Chalfie MY, Tu G, Euskirchen WW, et al. Green fluorescent protein as a marker for gene expression. Science, 1994, 263(5148): 802-805.
  • 10James DB, Ching-Tsan H. Recombinant plasmid retention and expression in bacterial biofilm cultures. Water Science and Technology, 1995, 31(2): 105-115.

二级参考文献1

共引文献13

同被引文献182

引证文献19

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部